Progyny, Inc. Operating Leases, Rent Expense
Progyny, Inc. (PGNY) reported Operating Leases, Rent Expense of $1.20 million for the 12-month period ending 2019-12-31, per its 10-K filed 2022-03-01.
Discontinued › Expense Statement › Operating Expenses
us-gaap:LeaseAndRentalExpense · last filed 2022-03-01
- Progyny, Inc. operating leases, rent expense for the quarter ending 2019-12-31 was -$666.80M.
- Progyny, Inc. operating leases, rent expense for the quarter ending 2018-12-31 was -$662.10M.
- Progyny, Inc. operating leases, rent expense for fiscal 2019 was $1.20M, a 33.33% increase from fiscal 2018.
- Progyny, Inc. operating leases, rent expense for fiscal 2018 was $900.00K, a 38.46% increase from fiscal 2017.
- Progyny, Inc. operating leases, rent expense for fiscal 2017 was $650.00K.
| Period end | Operating Leases, Rent Expense 3 month | Operating Leases, Rent Expense 9 month | Operating Leases, Rent Expense 12 month | Operating Leases, Rent Expense 12 month as first filed |
|---|---|---|---|---|
| 2019-12-31 | -$666.80M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $1.20M 10-K · filed 2022-03-01 | $1.17M 10-K · filed 2020-03-10 | |
| 2019-09-30 | $668.00M 10-Q · filed 2019-12-06 | |||
| 2018-12-31 | -$662.10M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | $900.00K 10-K · filed 2021-03-01 | $878.00K 10-K · filed 2020-03-10 | |
| 2018-09-30 | $663.00M 10-Q · filed 2019-12-06 | |||
| 2017-12-31 | $650.00K 10-K · filed 2020-03-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| agilon health, inc. (AGL) | United States | $1.272B | -7.76 |
| VIEMED HEALTHCARE, INC. (VMD) | United States | $0.336B | 29.92 |
| Park Dental Partners, Inc. (PARK) | United States | $0.094B | |
| BioRestorative Therapies, Inc. (BRTX) | United States | $0.064B | |
| CRYO CELL INTERNATIONAL INC (CCEL) | United States | $0.033B | -11.02 |
| MANGOCEUTICALS, INC. (MGRX) | United States | $0.010B | -0.43 |
| Sotera Health Co (SHC) | United States | $5.271B | 30.96 |
| DAVITA INC. (DVA) | United States | $11.147B | 16.80 |